ftInvstr
BROOKS · Healthcare ₹65.7 -0.39% Mkt Cap ₹194 Cr

BROOKS

Healthcare Drug Manufacturers - Specialty & Generic
₹65.7
-0.39% today · 30d -6.28%
as of 2026-11-09
Price · Daily Candles
AI narrative is temporarily unavailable for BROOKS. The deterministic sections below render from live data.
₹ Latest Earnings · Q ending 2026-09-30
REVENUE
₹19 Cr
-17.92% YoY
NET PROFIT
₹68 Cr
+747.57% YoY
OPM
6.45%
-5.77pp YoY
EPS
₹22.95
PE 14.95
Intrinsic value · DCF: N/A — ML model predicts severe Δ FCF compression (h1=-5.5%, h2=+6.4%, h3=-9.4% of mktcap), driving projected FCF negative by year 3 despite healthy current FCF. Treating as forecast outlier rather than reporting a misleading ₹0 valuation. Use the Strategy Fit and ML sections instead.
◇ Sector Position
PEERPEROCE %
BROOKS14.95-10.0
SUNPHARMA37.7921.44
DIVISLAB93.121.56
ZYDUSLIFE28.424.22
+ 2 more peers — sign in to view
ML Forward Growth Predictions 🔒

9 ML-predicted forward-growth ranks across sales, EBIT, and FCF.

Sign up freeSign in
51
SCORE / 100
Overall
6-axis composite of the sections below.
Performance UNDERPERFORMER 5
Valuation CHEAP 75
Growth MUTED 46
Profitability LOW 18
Technicals STRONG 72
Risk LOW 90
Key Stats
TTM PE
14.95
P/B
1.61
52W HIGH
₹123.54
OFF HIGH
-46.82%
DIV YIELD
0.0%
MKT CAP
₹194 Cr
◉ Active Signals
MACDBullish0.4039
RSI(14)Neutral54.43
⧉ Strategy Fit 🔒

See which of ftInvstr's 50+ strategies hold BROOKS and at what entry.

Sign up freeSign in